col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
American Association of Pharmaceutical Scientists: AAPS PharmSciTech
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―16 Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection Rama Kashikar, Arun Kumar Kotha, Rakshya Shrestha, Rudragouda Channappanavar, Mahavir Bhupal Chougule
2 [GO] 2025―Jan―03 Use of Remote Regulatory Assessment (RRA) for Site Evaluations during the COVID-19 Pandemic: The USFDA’s Office of Study Integrity and Surveillance (OSIS) Perspective Tahseen Mirza, Nicola Fenty-Stewart, Clint Mitchell, Brian Folian, Sean Kassim
3 [GO] 2024―Mrz―13 Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice Kanwal Khalid, Hui Xuan Lim, Ayaz Anwar, Soon Hao Tan, Jung Shan Hwang, Seng-Kai Ong, Chit Laa Poh
4 [GO] 2022―Nov―23 Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs Sayeed Mossadeq, Rajen Shah, Viraj Shah, Milind Bagul
5 [GO] 2022―Mrz―21 A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines Surojit Banerjee, Debadri Banerjee, Anupama Singh, Vikas Anand Saharan
6 [GO] 2021―Dez―29 Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19 Dina B. Mahmoud, Mohamed Mofreh Bakr, Ahmed A. Al-karmalawy, Yassmin Moatasim, Ahmed El Taweel, Ahmed Mostafa
7 [GO] 2021―Aug―10 Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19 Swati Sucharita Mohanty, Chita Ranjan Sahoo, Rabindra Nath Padhy
8 [GO] 2021―Jun―08 Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies Abdullah M Alnuqaydan, Abdulmajeed G Almutary, Arulmalar Sukamaran, Brian Tay Wei Yang, Xiao Ting Lee, Wei Xuan Lim, et al. (+20)
9 [GO] 2021―Apr―09 Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration Khaled AboulFotouh, Zhengrong Cui, Robert O. Williams
10 [GO] 2021―Feb―11 Technological Scenario for Masks in Patent Database During Covid-19 Pandemic Tatianny de Araújo Andrade, José Adão Carvalho Nascimento Junior, Anamaria Mendonça Santos, Lysandro Pinto Borges, Lucindo José Quintans-Júnior, Cristiani Isabel Banderó Walker, et al. (+2)
11 [GO] 2020―Okt―23 The Impact of Science-Unbased Measures Against COVID-19 in Clinical Decision-Making Process João Vitor Cândido Pimentel, Thaíse Duarte Onofre Sabiá e Silva, Ana Beatriz Tavares Filgueiras, Modesto Leite Rolim Neto
12 [GO] 2020―Okt―15 Analysis of Commercial Hand Sanitisers amid CoViD-19: Are We Getting the Products that We Need? Alberto Berardi, Beniamino Cenci-Goga, Luca Grispoldi, Lina Cossignani, Diego Romano Perinelli
13 [GO] 2020―Aug―05 The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation Jieliang Wang, Ying Peng, Haiyue Xu, Zhengrong Cui, Robert O. Williams
14 [GO] 2020―Aug―03 Diagnostic and Treatment Strategies for COVID-19 Humzah Jamshaid, Fatima Zahid, Intisar ud Din, Alam Zeb, Han Gon Choi, Gul Majid Khan, Fakhar ud Din
15 [GO] 2020―Mai―24 In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs Vadim J. Gurvich, Ajaz S. Hussain
16 [GO] 2020―Mai―13 Research Progress of Drug Treatment in Novel Coronavirus Pneumonia Junqiang Yan, Anran Liu, Jiarui Huang, Jiannan Wu, Hua Fan
 [1] 

16 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec